The INVIRAGEN brand, founded in 2003 (United States), from 440 sister brands and 4958 competing brands. The INVIRAGEN brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. The sector of INVIRAGEN is Drug Manufacturers.